We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
TIGS ink MoU with Central University of Tamil Nadu (CUTN)
TIGS and The Central University of Tamil Nadu sign an MoU to... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
Talk by Dr. Soumya Swaminathan
Honored to host Dr. Soumya Swaminathan, Chairperson, M S Swaminathan Research Foundation... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more
As COVID-19 cases increase, demand for ramping up genome sequencing rises
Director of Tata Institute of Genetics and Society (TIGS) Dr. Rakesh Mishra... read more
Technical Advisory Committee recommends sewage surveillance for early detection of Mpox in Karnataka
In a recently held meeting, the State Technical Advisory Committee (STAC) on... read more
Publication: Wastewater-based surveillance of vector-borne pathogens: a cautionary note
In our latest publication, Dr. Farah Ishtiaq provides a caution note on... read more
Rare Disease Day 2025
✨On 28th February i.e. Rare Disease Day 2025 , TIGS and NCBS... read more